Silexion Therapeutics SLXN Ratios (2023-2026)

NASDAQ SLXN
$0.27 -0.05 (-16.17%)
As of: Sep 30, 2026 · 2:23 PM EDT
Reported Financials

Silexion Therapeutics Quarterly Ratios

Periods 13 quarters
Latest Jun 2026

Silexion Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 4.42M2.95M2.70M2.98M5.59M7.05M8.71M9.41M5.91M4.42M
Equity AverageEquity Avg. 0.39M-10.06M-6.93M0.88M-2.21M-4.28M-0.70M1.35M3.55M4.79M1.45M0.17M
Invested CapitalInvested Cap. -15.48M-1.47M-1.03M5.58M3.31M8.52M4.17M
Leverage & Solvency
Interest Coverage RatioInterest Cover -70.37-150.00
Debt Ratio 1.011.030.360.550.130.22
Times Interest Earned -70.37-150.00
Valuation
Price to BookP/B 0.050.782.142.8858.680.550.9813.7539.84
Enterprise Value -6.15M1.05M-0.12M1.25M1.98M-1.63M0.07M1.31M3.58M-5.39M-3.44M1.59M-0.48M
Market Capitalization 0.30M1.05M1.05M1.25M0.33M0.34M1.25M7.46M7.04M3.85M2.55M4.00M1.75M
Return Ratios
Return on Capital Employed [ROCE]ROCE -869.28%-406.55%-282.92%-154.17%-174.75%-688.72%-3,153.35%
Return on Invested Capital [ROIC]ROIC -312.07%-154.32%-183.35%
Return on Assets [ROA]ROA -125.89%-182.51%-608.48%-554.69%-301.03%-253.03%-106.22%-126.53%-218.50%-315.51%
Return on Equity [ROE]ROE -610.78%-1,318.92%-260.59%-248.68%-892.19%-8,333.13%

Silexion Therapeutics Ratios API

Pull Silexion Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SLXN&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY